semaglutide commercial 💉 Struggling with weight loss? Real help is here. Wegovy® (semaglutide) is now more accessible than ever 👇 ✓ As low as $25/month with insurance ✓ Self-pay starting at $149 ✓ Novo sues Lilly, alleging 'misleading'

Cumulative health burden from untreated obesity is real

The company has acquired a European competitor, Zava, which already has 1.3 million customers for a range of productsincluding some obesity treatmentsin the UK, Ireland, Germany and France

GWAS summary results: diabetic retinopathy

The FDA prescribing information notes that tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis

It may prolong recovery time and delay the desired results of the fat dissolving treatment.To protect the skin and optimise the outcomes of the procedure, its advisable to avoid sun exposure and use sunscreen with a high SPF 50 on treated areas

Dankner R et al